Literature DB >> 23585461

Paraphilic diagnoses in DSM-5.

Richard B Krueger1, Meg S Kaplan.   

Abstract

BACKGROUND: The DSM-5 has been under revision since 1999 and is scheduled for publication in 2013. This article will review the major proposed modifications of the Paraphilias.
METHOD: The information reviewed was obtained from PubMed, PsychInfo, the DSM-5.org website and other sources and reviewed.
RESULTS: Pedohebephilia, Hypersexual Disorder and Paraphilic Coercive Disorder are new proposed diagnoses. Paraphilias have been assigned their own chapter in DSM- 5 and a distinction has been made between Paraphilias and Paraphilic Disorders. Victim numbers have been included in diagnosis of paraphilias that involve victims and remission and severity measures have been added to all paraphilias. Transvestic Disorder can apply to males or females, Fetishistic Disorder now includes partialism, and Sexual Masochism Disorder has Asphyxiophilia as a specifier. LIMITATIONS: This study is based on a literature review and influenced by the knowledge and biases of the authors.
CONCLUSIONS: The Paraphilic Disorders Section of the DSM-5 represents a significant departure from DSMIV-TR.

Entities:  

Mesh:

Year:  2012        PMID: 23585461

Source DB:  PubMed          Journal:  Isr J Psychiatry Relat Sci        ISSN: 0333-7308            Impact factor:   0.481


  3 in total

Review 1.  Problems with paraphilias in the DSM-5.

Authors:  J Paul Fedoroff; Lisha Di Gioacchino; Lisa Murphy
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

2.  The sexual attraction toward disabilities: a preliminary internet-based study.

Authors:  E Limoncin; R Carta; G L Gravina; E Carosa; G Ciocca; S Di Sante; A M Isidori; A Lenzi; E A Jannini
Journal:  Int J Impot Res       Date:  2013-09-19       Impact factor: 2.896

3.  Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up.

Authors:  Emir Celik; Hande Mefkure Ozkaya; Burc Cagri Poyraz; Tarik Saglam; Pinar Kadioglu
Journal:  Endocrine       Date:  2018-09-11       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.